Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Myelin Basic Protein-Specific TCR/HLA-DRB5*01:01 Transgenic Mice Support the Etiologic Role of DRB5*01:01 in Multiple Sclerosis.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
A phase II study of laquinimod in Crohn's disease.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
[Cognitive impairment in demyelinating disease].
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Optic neuritis in a child with biotinidase deficiency: case report and literature review.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Autoimmune myelopathies.
Nav1.5 sodium channels in macrophages in multiple sclerosis lesions.
Pages
« first
‹ previous
…
148
149
150
151
152
153
154
155
156
…
next ›
last »